SMI.London 2024 was the second conference dedicated to soft mist inhalers. During the event we learnt to make, develop, use, file, launch soft mist inhalers, and discovered their place in an inhaled therapy portfolio.

There was only one event dedicated to soft mist inhaler in the world  in 2024 (indeed +++), This was IT. We were glad to welcome so many delegates in London and build the future of soft mist inhalers together.

Speaker's Slides

About

In the UK, the number of SMI prescription is already outpacing nebuliser ones. It is only a matter of time before SMIs are on par with DPIs and gradually replace pMDIs with a true low carbon footprint pedigree. This will be a group effort and we all have a role to play to achieve this.

Merxin Ltd and the founding partners did a great job of inviting some of the most exciting speakers to the event. SMI.London 2024 was curated to illustrate how SMIs are taking their place alongside other inhalers and what benefits they are bringing. 

The speakers at SMI.London 2024 were key opinion leaders with extensive experience in the field of Inhaled Drug Delivery. We were most grateful they accepted to speak and chair sessions at SMI.London 2024.

SMI.London 2024 was a place to learn and to meet each other, the speed networking session of 20 minutes at the beginning of the day helped build the worldwide SMI community. This was a start and we will continue over the next few years.

The event was only possible thanks to the support of the Founding Partners, the Exhibitors and our Media Partners.

In the UK, the number of SMI prescription is already outpacing nebuliser ones. It is only a matter of time before SMIs are on par with DPIs and gradually replace pMDIs with a true low carbon footprint pedigree. This will be a group effort and we all have a role to play to achieve this.

Merxin Ltd and the founding partners did a great job of inviting some of the most exciting speakers to the event. SMI.London 2024 was curated to illustrate how SMIs are taking their place alongside other inhalers and what benefits they are bringing. 

The speakers at SMI.London 2024 were key opinion leaders with extensive experience in the field of Inhaled Drug Delivery. We were most grateful they accepted to speak and chair sessions at SMI.London 2024.

SMI.London 2024 was a place to learn and to meet each other, the speed networking session of 20 minutes at the beginning of the day helped build the worldwide SMI community. This was a start and we will continue over the next few years.

The event was only possible thanks to the support of the Founding Partners, the Exhibitors and our Media Partners.

For info about SMI.London 2024 and future events, contact info@SMI.London

The program of SMI.London 2024 is available for download here:

Slides

To request slides of the speakers, please use the links below.

Welcome Back To SMI.London: What happened Over The Last 12 months?

Dr. Philippe Rogueda, Chief Business Officer, Merxin Ltd

Plenary Lecture: Soft Mist Inhalers, A Comparison With Nebulizers

Dr. Darragh Murnane, Professor of Pharmaceutics, University of Hertfordshire

Administration Of Soft Mist Via Respiratory Supports - Nasal Delivery

Dr. Wei-Ren Ke, Assistant Professor, National Taiwan University School of Pharmacy

Test Method For A Check Valve For High Pressure Atomization In A Soft Mist Inhaler

Mr. Andre Widmann, Development Engineer Device Services, Harro Höfliger

What’s Your Target? Customizing Lung Delivery With Electrospray

Dr. Mehmet Uzumcu, Chief Scientific and Technology Officer, Gilbert

Characterizing Plume Development Using Tandem Aerodynamic Particle Sizers

Mr. Lance Jiang, Aerosol CDT PhD Researcher, University of Bristol

A ‘Whole Aerosol’ Approach for Aqueous Droplet Inhalations

Mr. Aurelien Martin, PhD Student, University of Hertfordshire

The Lifetime Of A Droplet: The Impact Of Droplet Microphysics And Aerosolisation Methods

Dr. Dan Hardy, Founder, Microsol Ltd

Transforming Respiratory Care With Soft Mist Biologics

Dr. Daniela Traini, Professor, Macquarie Medical School, Macquarie University

Oldies but Goldies: Repurposing Heparin for Lung Diseases

Dr. Ayca Yıldız-Peköz, Professor, Department of Pharmaceutical Technology, Instanbul University